Inactive Instrument

Highlights Bone Biologics Corporation Other OTC

Equities

BBLG

US0980702049

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Bone Biologics Corporation Reports Progress with NB1 Clinical Program	Mar. 01	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Bone Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Bone Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-15	CI
Bone Biologics to Receive Demineralized Bone Matrix Supply From MTF Biologics	22-03-07	MT
Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix	22-03-07	CI
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Bone Biologics Corporation has completed an IPO in the amount of $7.929889 million.	21-10-13	CI
Bone Biologics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Bone Biologics Corporation has filed an IPO in the amount of $6.8 million.	21-06-28	CI
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-21	CI
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI
Bone Biologics Announces Completion of Preclinical Study	20-01-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bone Biologics Corporation Other OTC

Equities

BBLG

US0980702049

Highlights

Filters